Norway· NO-ID_B821A98C-89B9-4C00-8325-EA7D1F3867B4
Veyvondi
A von willebrand factor product containing vonicog alfa, registered in Norway by Baxalta Innovations GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Von willebrand factor is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD10 (von willebrand factor), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Von willebrand factor · ATC B02BD10
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Vonicog Alfa
- Manufacturer
- Baxalta Innovations GmbH
- Country
- Norway (NO)
- ATC code
- B02BD10
- ATC class
- Von Willebrand factor
- Defined daily dose
- 1.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_B821A98C-89B9-4C00-8325-EA7D1F3867B4
- no_varenummer5692231NOK 8507.2
- gtin642621071702
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for von willebrand factor.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Von willebrand factor · interactions on record
2 records
- 2 severe
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Von willebrand factor in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVeyvondi 650 IUBaxalta Innovations
- SwedenVEYVONDI 650 IE Pulver och vätska till injektionsvätska, lösningBaxalta Innovations GmbH
- SwitzerlandVEYVONDI 1300 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- CzechiaVEYVONDIBaxalta Innovations GmbH, Vídeň
- FinlandVeyvondiBaxalta Innovations GmbH
- FranceVEYVONDI 1 300 UI poudre et solvant pour solution injectableBAXALTA INNOVATIONS (AUTRICHE)
- United KingdomVeyvondi 1,300unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandVEYVONDI 1300 IU powder and solvent for solution for injectionBaxalta Innovations GmbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Veyvondi
- Liechtenstein · Veyvondi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0672cbbb-c215-4346-bf76-59c1e6acb729 GET /v1/drugs/0672cbbb-c215-4346-bf76-59c1e6acb729?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Von Willebrand faktor",
"merkevare_id": "ID_B821A98C-89B9-4C00-8325-EA7D1F3867B4",
"name_form_strength": "Veyvondi pulv+væske til inj oppl 650 IE",
"prescription_group": "C"
}See everything about von willebrand factor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.